Iwasaki Is Honored by the International Cytokine & Interferon Society
Akiko Iwasaki, PhD, Waldemar Von Zedtwitz Profesor of Immunobiology and Molecular, Cellular, and Developmental Biology; and professor of dermatology, is a 2019 recipient of the Seymour & Vivian Milstein Award for Excellence in Interferon and Cytokine Research, given by the International Cytokine & Interferon Society (ICIS).
Antiretroviral Therapy Crucial in Preventing non-Hodgkin Lymphoma, YSPH Study Reinforces
A research team led by the Yale School of Public Health has found that for people living with HIV/AIDS, both recent immunosuppression and prolonged HIV viremia play important and independent roles in the development of non-Hodgkin lymphoma.
BioTechniques - Causing Cancer at (a Chromosome's) Arm's Length
“The question is, could this actually have some significance when it comes to treatment?” said Ayman El-Guindi, a molecular virologist at Yale University familiar with West and her research. He is certain that it does. El-Guindi pointed out that EZH2, an enzyme overexpressed in cancer cells, is a regulator of BIM. “If you can develop an inhibitor of EZH2 , then you have the opportunity of activating the expression of this gene,” said El-Guindi. In the case of EBV-related carcinogenesis, the reactivated BIM can resume its function to safeguard against cellular immortality and malignancy.
Joan Steitz named 2016 recipient of the DeVane Medal
Joan Steitz has been selected as the 2016 recipient of the DeVane Medal by the undergraduates of Yale's chapter of Phi Beta Kappa. More information about this honor and previous recipients can be found here: http://pbk.yalecollege.yale.edu/information/devane-medalists